Why the study?
What are the appropriate clinical and biomarker indicators for weaning off cardiopulmonary support in children with fulminant myocarditis?
Population
4 children with fulminant myocarditis treated with cardiopulmonary support (CPS), mean age 9 years.
Design
Case_series
Authors
Loading...
SvO2 and biomarker trends may guide CPS weaning in pediatric fulminant myocarditis; leaves open prospective validation before practice change.
What are the appropriate clinical and biomarker indicators for weaning off cardiopulmonary support in children with fulminant myocarditis?
In children with fulminant myocarditis, CPS can be safely discontinued based on improvements in biomarkers and SvO2 before bleeding episodes become symptomatic.
Kanamaru et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: